Veradigm | MDRX - Market Capitalization

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $487.8M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 134.3M 53.72M Jun/2025
Ambu A/S DKK 19.93B 16.79B Feb/2026
Amplifon EUR 3.14B 1.38B Sep/2025
Cardinal Health USD 54.98B 6.15B Feb/2026
Centene USD 19.14B 1.08B Feb/2026
Charles River Laboratories USD 8.08B 1.94B Feb/2026
Cigna USD 80.66B 7.14B Feb/2026
Computer Programs Systems USD 163M 69M Dec/2023
Convatec Group USD 8.12B 3.58B Jun/2025
CVS Health USD 98.76B 1.98B Feb/2026
Diasorin EUR 4.23B 858.25M Sep/2025
Elevance Health USD 77.91B 5.15B Dec/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Gulf Medical Proj AED 1.4B 62.9M Jun/2025
Humana USD 21.14B 9.66B Feb/2026
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Laboratory Of America USD 23.27B 2.47B Feb/2026
Maximus USD 4.77B 73M Feb/2026
McKesson USD 108.02B 6.77B Feb/2026
Med Life RON 4.16B 601.5M Sep/2025
Molina Healthcare USD 10.36B 1.44B Feb/2026
Omnicell USD 1.8B 238M Feb/2026
Oriola-kd EUR 148.91M 64.21M Feb/2026
Owens Minor USD 371M 326M Sep/2025
Quest Diagnostics USD 23.09B 3.79B Feb/2026
Rede D'or Sao Luiz BRL 96.33B 18.17B Sep/2025
Siemens Healthineers EUR 45.64B 5.03B Feb/2026
Supermax Corporation Bhd MYR 1.47B 340.88M Sep/2025
UnitedHealth USD 265.18B 33.84B Feb/2026
Veeva Systems USD 47.73B 1.29B Sep/2025
Veradigm USD 1.69B 34M Sep/2022